CR10267A - Agente terapéutico o profiláctico para el síndrome de colon irritable - Google Patents

Agente terapéutico o profiláctico para el síndrome de colon irritable

Info

Publication number
CR10267A
CR10267A CR10267A CR10267A CR10267A CR 10267 A CR10267 A CR 10267A CR 10267 A CR10267 A CR 10267A CR 10267 A CR10267 A CR 10267A CR 10267 A CR10267 A CR 10267A
Authority
CR
Costa Rica
Prior art keywords
agent
profilactic
therapeutic
optionally substituted
hydrocarbon group
Prior art date
Application number
CR10267A
Other languages
English (en)
Inventor
Jun Terauchi
Fumihiko Sato
Nobuhiro Inatomi
Original Assignee
Takeda Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38522471&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CR10267(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Takeda Pharmaceutical filed Critical Takeda Pharmaceutical
Publication of CR10267A publication Critical patent/CR10267A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)

Abstract

La presente invención describe un agente para prevenir/tratar el síndrome de colon irritable, que comprende un compuesto representado por la fórmula (I) a continuación o su sal donde, R1 representa un grupo hidrocarbonado opcionalmente sustituido, o similar, R2 representa un átomo de hidrógeno o un grupo hidrocarbonado opcionalmente sustituido; R3 representa un átomo de hidrógeno, un grupo hidrocarbonado opcionalmente sustituido, o similar; X representa CHR4, NR4, CO, O o S (donde, R4 representa un átomo de hidrógeno, un grupo hidrocarbonado opcionalmente sustituido, o similar).
CR10267A 2006-03-20 2008-08-29 Agente terapéutico o profiláctico para el síndrome de colon irritable CR10267A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2006076532 2006-03-20

Publications (1)

Publication Number Publication Date
CR10267A true CR10267A (es) 2008-11-18

Family

ID=38522471

Family Applications (1)

Application Number Title Priority Date Filing Date
CR10267A CR10267A (es) 2006-03-20 2008-08-29 Agente terapéutico o profiláctico para el síndrome de colon irritable

Country Status (19)

Country Link
US (2) US20090048325A1 (es)
EP (1) EP1997488A4 (es)
JP (1) JP5219799B2 (es)
KR (1) KR20080114743A (es)
CN (1) CN101404994A (es)
AR (1) AR059935A1 (es)
AU (1) AU2007228087A1 (es)
BR (1) BRPI0708805A2 (es)
CA (1) CA2644181A1 (es)
CR (1) CR10267A (es)
IL (1) IL193686A0 (es)
MA (1) MA30326B1 (es)
MX (1) MX2008011969A (es)
NO (1) NO20084214L (es)
PE (1) PE20080122A1 (es)
RU (1) RU2008141305A (es)
TW (1) TW200803837A (es)
WO (1) WO2007108442A1 (es)
ZA (1) ZA200807752B (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023059546A1 (en) * 2021-10-04 2023-04-13 Psilosterics, Llc Serotonin receptor agonists and methods of making and using the same

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9326192D0 (en) * 1993-12-22 1994-02-23 Glaxo Group Ltd Chemical compounds
ES2175350T5 (es) * 1996-03-08 2008-12-16 Takeda Pharmaceutical Company Limited Compuestos triciclicos que tienen afinidad de union a receptores de melatonina, su produccion y uso.
US6034239A (en) 1996-03-08 2000-03-07 Takeda Chemical Industries, Ltd. Tricyclic compounds, their production and use
JP2884153B2 (ja) * 1996-03-08 1999-04-19 武田薬品工業株式会社 三環性化合物、その製造法および剤
EP1100508B8 (en) * 1998-06-09 2004-01-07 Takeda Chemical Industries, Ltd. Pharmaceutical combination comprising a tricyclic compound and at least one of zolpidem, zopiclone and brotizolam for treating or preventing sleep disorders
FR2795323B1 (fr) * 1999-06-23 2001-11-16 Adir Utilisation de ligands melatoninergiques pour l'obtention de compositions pharmaceutiques destinees a la prevention ou au traitement des pathologies du systeme gastrointestinal
JP2002226367A (ja) 2001-02-02 2002-08-14 Fuji Chem Ind Co Ltd 薬物障害の予防または治療剤
US20050203130A1 (en) * 2003-12-02 2005-09-15 Erik Buntinx Use of D4 and 5-HT2A antagonists, inverse agonists or partial agonists
AR056076A1 (es) * 2005-09-20 2007-09-19 Takeda Pharmaceutical Agente profilactico o terapeutico para el desorden de sueno
US20070088079A1 (en) * 2005-09-20 2007-04-19 Takeda Pharmaceutical Company Limited Prophylactic or therapeutic agent for sleep disorder
US8138174B2 (en) * 2007-01-10 2012-03-20 Solvay Pharmaceuticals B.V. Compounds with a combination of cannabinoid CB1 antagonism and serotonin reuptake inhibition

Also Published As

Publication number Publication date
US20100267821A1 (en) 2010-10-21
RU2008141305A (ru) 2010-04-27
ZA200807752B (en) 2009-12-30
IL193686A0 (en) 2009-08-03
CN101404994A (zh) 2009-04-08
EP1997488A1 (en) 2008-12-03
EP1997488A4 (en) 2010-04-21
NO20084214L (no) 2008-10-08
BRPI0708805A2 (pt) 2011-06-14
PE20080122A1 (es) 2008-04-24
AU2007228087A1 (en) 2007-09-27
JP5219799B2 (ja) 2013-06-26
US20090048325A1 (en) 2009-02-19
US8183285B2 (en) 2012-05-22
CA2644181A1 (en) 2007-09-27
WO2007108442A1 (ja) 2007-09-27
MX2008011969A (es) 2008-10-03
MA30326B1 (fr) 2009-04-01
JPWO2007108442A1 (ja) 2009-08-06
TW200803837A (en) 2008-01-16
KR20080114743A (ko) 2008-12-31
AR059935A1 (es) 2008-05-07

Similar Documents

Publication Publication Date Title
ECSP099330A (es) Compuesto de indol
GT200500242A (es) Procesos para la preparaciòn de 2-(2,6-dioxopiperidin-3-il)-1-oxoisoindolinas sustituidas
AR061644A1 (es) Derivados de benzofurano
CO6160266A2 (es) Derivado de oxopirazina y herbicida
WO2008083252A3 (en) Methods of use for cyclopamine analogs
GT200600342A (es) Compuestos de cicloalquilo amino-hidantoina y uso de estos para la modulacion de beta-secretasa
TW200633990A (en) Amide compound
DOP2010000068A (es) Derivados de pirazol sustituidos
DK1853602T3 (da) Kemiske forbindelser
CY1108275T1 (el) Χημικες ενωσεις
BRPI0609785B8 (pt) benzotiofenos substituídos por piperazina, composição farmacêutica, processo para produzir uma composição farmacêutica, uso de benzotiofenos substituídos por piperazina ou um sal do mesmo, e, processo para produzir benzotiofenos substituídos por piperazina
MX343611B (es) Composicion de control de fitoenfermedades y su uso.
ECSP088369A (es) Novedosos derivados de 1-aza-bicicloalquilo para el tratamiento de trastornos psicóticos y neurodegenerativos
CO6251235A2 (es) Compuestos derivados de azetidinas su preparacion y su aplicacion en terapeutica
ATE493410T1 (de) Neue verbindung mit affinität zu amyloid
EA200600878A1 (ru) Производные феноксиуксусных кислот, применимые в качестве двойных агонистов активируемого пероксисомным пролифератором рецептора ( ppar )
EA200970555A1 (ru) Трициклическое соединение и его медицинское применение
AR054583A1 (es) Pantoprazol isotopicamente sustituido
CR10267A (es) Agente terapéutico o profiláctico para el síndrome de colon irritable
GT200500338A (es) Nuevos inhibidores de hmg co-a reductasa basados en pirazol
CO6280473A2 (es) Compuestos de 1,2,4- triazin-3,5-diona adecuados para el tratamiento de trastornos que responden a la modulacion del receptor de dopamina d3
GEP20074256B (en) Novel benzothiadiazine, process for their preparation and pharmaceutical compositions containing
EP1845780A4 (en) USES OF METHYLPHENIDATE DERIVATIVES
NI200700323A (es) 4-anilino-3-quinolinocarbonitrilo para el tratamiento de cáncer
ATE521614T1 (de) Verfahren zur herstellung von trimethylsilylazid

Legal Events

Date Code Title Description
FA Abandonment or withdrawal (granting procedure)